Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 9Pancreatic Neoplasms 3Biliary Tract Neoplasms 3Locally Advanced Gastric Cancer 2Cholangiocarcinoma 2Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Pancoast Syndrome 1Neoplasms 1Gastric Cancer Peritoneal Metastases 1Gastric Adenocarcinoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Efficacy and Safety 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of the Stomach 1

Interventions

camrelizumab 2S 1 (combination) 2Oxaliplatin 2apatinib 1Taxes 1Hyperthermic Intraperitoneal Chemotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Locally Advanced Gastric Cancer × S 1 (combination) × Clear all
NCT07621484 2026-06-02

HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer

Shanghai Changzheng Hospital

Phase 2 Not yet recruiting
48 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

NCT05524974 2022-09-01

Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes

Fujian Medical University

Phase 2 Not yet recruiting
203 enrolled
Gastrointestinal

Locally Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡